Загрузка...
Docosahexaenoic acid is a beneficial replacement treatment for spinocerebellar ataxia 38
OBJECTIVE: Spinocerebellar ataxia 38 (SCA38) is caused by mutations in the ELOVL5 gene, which encodes an elongase involved in the synthesis of polyunsaturated fatty acids, including docosahexaenoic acid (DHA). As a consequence, DHA is significantly reduced in the serum of SCA38 subjects. In the pres...
Сохранить в:
| Опубликовано в: : | Ann Neurol |
|---|---|
| Главные авторы: | , , , , , , , , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5698802/ https://ncbi.nlm.nih.gov/pubmed/28976605 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.25059 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|